The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma
Recommended Citation
Bhatnagar AR, Ghanem AI, Alkamachi B, Allo G, Lin CH, Hijaz M, and Elshaikh MA. The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma. Gynecol Oncol 2024; 188:44-51.
Document Type
Article
Publication Date
9-1-2024
Publication Title
Gynecologic oncology
Abstract
OBJECTIVE: Substantial lymphovascular space invasion (LVSI) is an important predictor of lymph node (LN) involvement in women with endometrial carcinoma. We studied the prognostic significance of substantial LVSI in patients with 2009-FIGO stage-I uterine endometrioid adenocarcinoma (EC) who all had pathologic negative nodal evaluation (PNNE).
METHODS: Pathologic specimens were retrieved and LVSI was quantified (focal or substantial) in women with stage-I EC who had a hysterectomy and PNNE. In addition to multivariate analysis (MVA), recurrence-free (RFS), disease-specific (DSS), and overall (OS) survival was compared between women with focal vs. substantial LVSI.
RESULTS: 1052 patients were identified with a median follow-up of 9.7 years. 358 women (34%) received adjuvant radiotherapy. 907 patients (86.2%) had no LVSI, 87 (8.3%) had focal, and 58 (5.5%) had substantial LVSI. Five-year RFS was 93.3% (95% CI: 91.5-95.1), 76.8% (95% CI: 67.2-87.7) and 79.1% (95% CI: 67.6-95.3) for no, focal, and substantial LVSI(p < 0.0001). There was no statistically significant difference in 5-year RFS, DSS, OS, and in the patterns of initial recurrence between women with focal vs substantial LVSI. On MVA with propensity score matching, substantial LVSI was not independently associated with any survival endpoint compared to focal LVSI, albeit both were detrimental when compared to no LVSI. Age ≥ 60 years and higher grade were predictors of worse RFS, DSS, and OS. Additionally, comorbidity burden was an independent predictor for OS.
CONCLUSIONS: Our results suggest that substantial LVSI does not predict worse survival endpoints or different recurrence patterns in women with stage-I EC with PNNE when compared to focal LVSI.
Medical Subject Headings
Humans; Female; Middle Aged; Neoplasm Staging; Aged; Prognosis; Carcinoma, Endometrioid; Neoplasm Invasiveness; Lymphatic Metastasis; Endometrial Neoplasms; Lymph Nodes; Adult; Aged, 80 and over; Uterine Neoplasms; Retrospective Studies; Hysterectomy
PubMed ID
38936280
Volume
188
First Page
44
Last Page
51
